Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...
Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...
In my book, it's a company that's built a long track ... Following in the steps of its rival Eli Lilly (LLY), Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is cutting the ...
Wall Street likes the company's promising pipeline ... this weight-loss drug stock could more than 3x over the next 12 ...
The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.
While the Super Bowl may not always be the ideal spot for pharma, cultural events like the Oscars can offer a more ...
Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the ...
Despite comments made by a Novo Nordisk official this week, the company confirmed to BioSpace that it has no additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback